Clarivate Plc (CLVT)
NYSE: CLVT · Real-Time Price · USD
1.740
+0.130 (8.07%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Clarivate Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,413 | 2,455 | 2,557 | 2,629 | 2,660 | 1,877 |
Revenue Growth | -3.50% | -3.97% | -2.74% | -1.17% | 41.71% | 49.66% |
Gross Profit Gross Profit Growth | 1,612 | 1,622 | 1,688 | 1,722 | 1,706 | 1,251 |
Operating Income Operating Income Growth | 164.2 | 172.1 | 234.2 | 274.7 | 266.3 | 62.1 |
Net Income Net Income Growth | -334 | -201.1 | -668 | -986.6 | -4,036 | -312 |
Earnings Per Share EPS Growth | -0.51 | -0.30 | -0.96 | -1.47 | -6.24 | -0.61 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Academia and Government Academia and Government Growth | 1,240 | 1,266 | 1,326 | 1,323 | 1,280 | 489.4 |
Intellectual Property Intellectual Property Growth | 799.7 | 799.4 | 811.4 | 862.7 | 927.1 | 974.3 |
Life Sciences and Healthcare Life Sciences and Healthcare Growth | 373.1 | 389.8 | 418.9 | 442.8 | 452.6 | 413.2 |
Total Total Growth | 2,413 | 2,455 | 2,557 | 2,629 | 2,660 | 1,877 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 206.7 | 319.8 | 284.7 | 374.8 | 359.1 | 430.9 |
Total Debt Total Debt Growth | 4,258 | 4,483 | 4,594 | 4,810 | 5,104 | 5,613 |
Net Cash (Debt) Net Cash Growth | -4,051 | -4,163 | -4,309 | -4,435 | -4,745 | -5,182 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -6.23 | -6.18 | -6.21 | -6.60 | -6.99 | -8.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 574.4 | 628.5 | 646.6 | 744.2 | 509.3 | 323.8 |
Capital Expenditures CapEx Growth | -246.8 | -263.2 | -289.1 | -242.5 | -202.9 | -118.5 |
Free Cash Flow Free Cash Flow Growth | 327.6 | 365.3 | 357.5 | 501.7 | 306.4 | 205.3 |
Free Cash Flow Growth | -5.32% | 2.18% | -28.74% | 63.74% | 49.24% | 31.77% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.82% | 66.05% | 66.00% | 65.52% | 64.13% | 66.64% |
Operating Margin | 6.80% | 7.01% | 9.16% | 10.45% | 10.01% | 3.31% |
Pretax Margin | -14.03% | -7.90% | -21.66% | -38.52% | -149.98% | -13.76% |
Profit Margin | -13.84% | -8.19% | -26.13% | -37.53% | -151.73% | -16.62% |
FCF Margin | 13.58% | 14.88% | 13.98% | 19.09% | 11.52% | 10.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 2.54 | 5.00 | 7.05 | 11.31 | 11.13 | 27.13 |
P/FCF Ratio | 3.40 | 6.05 | 10.10 | 12.25 | 18.35 | 78.67 |
PS Ratio | 0.46 | 0.90 | 1.41 | 2.34 | 2.11 | 8.61 |